MAP2K7 and breast cancer: Further studies indicated that cross-talk between ERalpha+ and Raf/MEK/ERK signaling pathways is a key oncogenic axis which is responsible in part for the development of ER-independent growth of breast cancers which were initially ERalpha+ and hormone sensitive.